• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Microbiol A Public Health Laboratory Response to the COVID-19 Pandemic

tetano

Editor, Senior Moderator
J Clin Microbiol


. 2020 Jun 8;JCM.01110-20.
doi: 10.1128/JCM.01110-20. Online ahead of print.
A Public Health Laboratory Response to the COVID-19 Pandemic


Kanti Pabbaraju[SUP] 1 [/SUP], Anita A Wong[SUP] 2 [/SUP], Mark Douesnard[SUP] 2 [/SUP], Raymond Ma[SUP] 2 [/SUP], Kara Gill[SUP] 2 [/SUP], Paul Dieu[SUP] 2 [/SUP], Kevin Fonseca[SUP] 2 3 [/SUP], Nathan Zelyas[SUP] 4 5 [/SUP], Graham A Tipples[SUP] 4 5 6 [/SUP]



Affiliations

Abstract

An outbreak of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) began in Wuhan, Hubei, China, in December 2019, and spread rapidly worldwide. The response by the Alberta Precision Laboratories, Public Health Laboratory (ProvLab), Alberta, Canada, included the development and implementation of nucleic acid detection based assays and dynamic changes in testing protocols for the identification of cases as the epidemic curve increased exponentially. This rapid response was essential to slow down and contain transmission and provide valuable time to the local health authorities to prepare appropriate response strategies. As of May 24, 2020, 236,077 specimens were tested with 6475 (2.74%) positives detected in the province of Alberta, Canada. Several commercial assays are now available; however, the response from commercial vendors to develop and market validated tests is a time-consuming process. In addition, the massive global demand made it difficult to secure a reliable commercial supply of testing kits and reagents.A public health laboratory serves a unique and important role in the delivery of health care. One of its functions is to anticipate and prepare for novel emerging pathogens with a plan for pandemic preparedness. Here we outline the response that involved the development and deployment of testing methodologies that evolved as SARS-CoV-2 spread world-wide, the challenges encountered, and mitigation strategies. We also provide insight into the organizational structure of how a public health response is coordinated in Alberta and its benefits.
 
Back
Top Bottom